These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11473501)
1. Forty years of antidepressant drug trials. Barbui C; Hotopf M Acta Psychiatr Scand; 2001 Aug; 104(2):92-5. PubMed ID: 11473501 [TBL] [Abstract][Full Text] [Related]
2. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. Khin NA; Chen YF; Yang Y; Yang P; Laughren TP J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123 [TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach. Tedeschini E; Fava M; Papakostas GI J Clin Psychiatry; 2011 Jan; 72(1):98-113. PubMed ID: 21208576 [TBL] [Abstract][Full Text] [Related]
5. Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. Khan A; Kolts RL; Thase ME; Krishnan KR; Brown W Am J Psychiatry; 2004 Nov; 161(11):2045-9. PubMed ID: 15514405 [TBL] [Abstract][Full Text] [Related]
6. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
7. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials. Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319 [TBL] [Abstract][Full Text] [Related]
8. A multistage analysis strategy for a clinical trial to assess successively more stringent criteria for a primary endpoint with a low event rate. Li S; Hussey MA; Schwartz TA; Koch GG Pharm Stat; 2013; 12(2):65-73. PubMed ID: 23424092 [TBL] [Abstract][Full Text] [Related]
9. Nonconventional clinical trial designs: approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost. Howard G Stroke; 2007 Feb; 38(2 Suppl):804-8. PubMed ID: 17261743 [TBL] [Abstract][Full Text] [Related]
10. Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis. Cipriani A; Malvini L; Furukawa TA; Barbui C J Clin Psychopharmacol; 2007 Aug; 27(4):352-6. PubMed ID: 17632218 [TBL] [Abstract][Full Text] [Related]
11. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. Seemüller F; Möller HJ; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Schennach-Wolff R; Henkel V; Riedel M J Clin Psychiatry; 2010 Nov; 71(11):1425-33. PubMed ID: 20816028 [TBL] [Abstract][Full Text] [Related]
12. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Taylor WD; Doraiswamy PM Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391 [TBL] [Abstract][Full Text] [Related]
13. Are antidepressants overrated? A review of methodological problems in antidepressant trials. Moncrieff J J Nerv Ment Dis; 2001 May; 189(5):288-95. PubMed ID: 11379971 [TBL] [Abstract][Full Text] [Related]
14. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression. Papakostas GI; Martinson MA; Fava M; Iovieno N J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092 [TBL] [Abstract][Full Text] [Related]
15. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder? Iovieno N; Papakostas GI J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of depression in multiple sclerosis. Koch MW; Glazenborg A; Uyttenboogaart M; Mostert J; De Keyser J Cochrane Database Syst Rev; 2011 Feb; (2):CD007295. PubMed ID: 21328292 [TBL] [Abstract][Full Text] [Related]
17. Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research. Gaudiano BA; Herbert JD Psychother Psychosom; 2005; 74(1):17-25. PubMed ID: 15627852 [TBL] [Abstract][Full Text] [Related]